Knowledge@Wharton: Lowering Drug Prices: Will the Cost Outweigh the Cure?

“ ‘You’ll see kind of the Carrier Corporation story – some drug companies will reduce the prices of some of their high priced products just to go with the program,’ said Mark Pauly, Wharton professor of health care management. He was referring to Trump’s unsuccessful efforts to prevent layoffs at the company’s Indianapolis plant last year. ‘The long-term effects are unlikely to be very large on overall drug prices’.” Read more at Knowledge@Wharton